Treatment patterns and clinical outcomes for patients with de novo versus recurrent HER2-positive metastatic breast cancer. [electronic resource]
Producer: 20150112Description: 725-34 p. digitalISSN:- 1573-7217
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Antineoplastic Agents -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bone Neoplasms -- drug therapy
- Breast Neoplasms -- drug therapy
- Cohort Studies
- Disease-Free Survival
- Female
- Humans
- Liver Neoplasms -- drug therapy
- Lung Neoplasms -- drug therapy
- Lymphatic Metastasis
- Neoplasm Recurrence, Local -- pathology
- Prospective Studies
- Receptor, ErbB-2 -- metabolism
- Trastuzumab
- Treatment Outcome
- Tumor Burden
No physical items for this record
Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.